Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Pre-exposure Prophylaxis: full-pipeline trial registry

5 of 13 indexed Pre-exposure Prophylaxis trials are currently recruiting.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 5 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Pre-exposure Prophylaxis: 13 US clinical trials tracked, 5 recruiting.

Pre-exposure Prophylaxis is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Public Health Foundation Enterprises, running 2 of these trials.

Enrollment posture brief

Registry condition pre-exposure-prophylaxis

OPEN 5 | RECR 38% | LATE 2 | EARLY 2 | RANK #1315 | SPON 2

Nearest open-share peer: Anaplastic Oligodendroglioma (38% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Pre-exposure Prophylaxis (th…38%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Pre-exposure Prophylaxis

Pre-exposure Prophylaxis lists 5 open slots (38% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pre-exposure Prophylaxis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pre-exposure Prophylaxis is recruiting below its size-band peers.

    5 of 13 indexed trials (38.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Pre-exposure Prophylaxis research.

    Public Health Foundation Enterprises accounts for 2 of 13 trials (15.4%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Typical Pre-exposure Prophylaxis enrolment sits around 158 participants.

    Median target enrolment is 158 among the 13 trials that report a genuine target (sentinel values excluded). 4 of those (30.8%) plan for fewer than 100 participants.

  4. Pre-exposure Prophylaxis research is mostly interventional.

    12 interventional and 1 observational studies make up this index (92.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 42

Open and recent trials

13 total, page 1 of 1

RECRUITING NA 500 participants

Gathering Online for Dialogue and Discussion to Enhance Social Support

RTI International

NCT05753683

RECRUITING NA 458 participants

Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program

University of Washington

NCT05856942

RECRUITING NA 180 participants

Case Management Dyad

University of Chicago

NCT06162897

RECRUITING NA 175 participants

Stick2PrEP Cisgender Women and Trans Individuals

Columbia University

NCT05165745

RECRUITING 100 participants

Predictors of Health Service Utilizations Among Key Population in Washington DC

Us Helping Us, People Into Living

NCT06046079

ACTIVE NOT RECRUITING Early Phase 1 24 participants

Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero

University of Illinois at Chicago

NCT05929521

COMPLETED NA 314 participants

Information Seeking About Pre-exposure Prophylaxis

Penn State University

NCT05728034

COMPLETED NA 229 participants

PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention

ETR Associates

NCT04902820

COMPLETED Phase 4 158 participants

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

Public Health Foundation Enterprises

NCT03120936

COMPLETED NA 100 participants

Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK

University of Arkansas

NCT04064567

COMPLETED NA 50 participants

Optimizing PrEP Adherence for Young Men Who Have Sex With Men

Fenway Community Health

NCT03493555

COMPLETED Phase 4 20 participants

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

Public Health Foundation Enterprises

NCT03387462

COMPLETED Early Phase 1 15 participants

Assessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers

Indiana University

NCT03202511

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 4 2

Named interventions

Most-linked intervention names on Pre-exposure Prophylaxis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Emtricitabine / Tenofovir Disoproxil Oral Tablet Drug
2 trials
DOT Diary mobile app Other
1 trials
Tenofovir disoproxil fumarate/Emtricitabine Drug
1 trials
PrEP support Behavioral
1 trials
PrEP-LINK Behavioral
1 trials
Online PrEP resource list Other
1 trials
PrEPTECH website Other
1 trials
Peer Health Navigator for PrEP Behavioral
1 trials

US sites by state

Facility locations filed on Pre-exposure Prophylaxis trials. A trial with sites in several states counts in each.

California 3 trials
Illinois 2 trials
Washington 1 trials
Pennsylvania 1 trials
New York 1 trials
North Carolina 1 trials
Massachusetts 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pre-exposure Prophylaxis page

13 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pre-exposure Prophylaxis condition card totals 13 registered trials; most-linked intervention Emtricitabine / Tenofovir Disoproxil Oral Tablet; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.